EIT Health Scandinavia
Skip to content
  • Our Programmes
    • Accelerator Programmes
    • Education Programmes
    • Innovation Programmes
  • Biobanks & Health Data Registers
    • Information Hub
    • Essential initial considerations
    • Biobanks
      • Biobanks country specific overview
      • Biobanks fact sheets
    • Health Data Registers
    • How to Access Biobanks and Health Data Registers
    • About the Information Hub
    • Useful contacts
  • Opportunities & Events
    • Opportunities
    • Events
  • News & Reports
    • News Room
    • Mobilising against COVID-19
    • Download Content
    • EIT Health in the media
  • About
    • About EIT Health Scandinavia
    • Partners
    • Scandinavian Team
    • Scandinavian Board
    • EIT Health Alumni
  • Our Programmes
    • Accelerator Programmes
    • Education Programmes
    • Innovation Programmes
  • Biobanks & Health Data Registers
    • Information Hub
    • Essential initial considerations
    • Biobanks
      • Biobanks country specific overview
      • Biobanks fact sheets
    • Health Data Registers
    • How to Access Biobanks and Health Data Registers
    • About the Information Hub
    • Useful contacts
  • Opportunities & Events
    • Opportunities
    • Events
  • News & Reports
    • News Room
    • Mobilising against COVID-19
    • Download Content
    • EIT Health in the media
  • About
    • About EIT Health Scandinavia
    • Partners
    • Scandinavian Team
    • Scandinavian Board
    • EIT Health Alumni

Home / almi invest

Earlier projects

​€750 000 to EIT Health company Resitu Medical

The medical technology company Resitu Medical AB, working with an innovative solution for tumor biopsies, announced today that Almi Invest, Stockholm Business Angels (STOAF) and private investors have invested €750 000 in the company. The investment will be used to initiate a development project aiming for CE marking in 2023. An additional SEK 20 million will be raised through equity.

Learn more

7,5 miljoner till EIT Health bolaget Resitu Medical

Medicinteknikföretaget Resitu Medical AB som jobbar med en innovativ lösning för tumörbiopsier meddelar att Almi Invest, Stockholm Affärsänglar (STOAF) och privata investerare går in med 7,5 miljoner kronor i bolaget. Finansieringen kommer att användas för att starta ett utvecklingsprojekt med sikte på CE-märkning under 2023. Ytterligare minst 20 MSEK kommer behöva tas in via ägarkapital.

Learn more
Navigation

Home
Biobanks & Health Data
Opportunities & Events
News
About EIT Health Scandinavia

Contact

EIT Health Scandinavia
Torsgatan 11
111 23 Stockholm, Sweden
scandinavia@eithealth.eu

© EIT Health Scandinavia 2023

  • Privacy Policy